The popular antibiotic Levaquin was approved by the FDA in 1996. However, in July 2008 the FDA warned consumers that Levaquin (adn other drugs in the fluoroquinolone class of antibiotics) put users at a heightened risk for developing tendonitis and tendon ruptures. The FDA ordered the drug’s manufacturer, Ortho-McNeil Pharmaceutical, Inc. (a subsidiary of Johnson & Johnson) to include a label warning about the heightened risk of tendonitis and tendon ruptures.

The most serious type of tendon injury commonly associated with Levaquin is a ruptures achilles tendon, which typically requires surgery and extensive rehabilitation. Other types of related injuries are tendon ruptures of the rotator cuff, hand, biceps and thumb. Most of these injuries occur either shortly after completing the dose of Levaquin or within several months.

There have already been numerous lawsuits filed across the U.S. The pending Levaquin lawsuits have recently received mass tort designation because there could potentially be thousands filed. The cases have  been consolidated in a MDL (Multi-District Litigation) because of the complex issues involved and the common issues of law and fact.
Kay L. Van Wey
VAN WEY LAW, P.L.L.C.
3100 Monticello, Suite 500
Dallas, Texas   75205
214-265-7600
kayvanwey@gmail.com

Posted via email from Kay’s Posterous

It has been alleged that from 2004-2008 Yaz/Yasmin has caused more than 50 deaths, some of these in women as young as 17.  These deaths have been associated with cardiac arrythmia, cardiac arrest, intracardiac thrombus, pulmonary embolism and stroke.

Bayer has heavily marketed Yas/Yasmin to young women and has reaped enormous profits through its sales. However, Bayer has continued to minimize the known risks and side effects so as to “not make its customers uneasy” [Hubert Ostendorf-Coalition against Bayer Dangers].

Lawsuits have been filed throughout the United States and have recently been consolidated into a Multi-District Litigation [MDL] in order to streamline discovery and avoid inconsistent rulings.  VanWeyLaw is currently representing Yaz/Yasmin victims.  If you or a loved one have taken Yaz/Yasmin and have suffered a serious injury, such as pulmonary embolism, deep vein thrombosis, stroke, cardiac arrest or death, please contact kay@vanweylaw.com for further information.

Posted via email from Kay’s Posterous